In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
June 21st, 2011 | 32 | No |
Popular Name: 4-[6-[4-(2-morpholinoethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]benzene-1,2-diol 4-[6-[4-(2-morpholinoethoxy)phen…
None
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.20 | 4.72 | -13.82 | 2 | 8 | 0 | 92 | 432.48 | 6 | ↓ |
Mid Mid (pH 6-8) | 3.20 | 7.01 | -49.18 | 3 | 8 | 1 | 94 | 433.488 | 6 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AAKB1-1-E | AMP-activated Protein Kinase, Beta-1 Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1100 | 0.26 | Binding ≤ 10μM |
AAKG1-1-E | AMP-activated Protein Kinase, Gamma-1 Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1100 | 0.26 | Binding ≤ 10μM |
AAPK2-1-E | AMP-activated Protein Kinase, Alpha-2 Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1100 | 0.26 | Binding ≤ 10μM |
EPHA2-1-E | Ephrin Type-A Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 740 | 0.27 | Binding ≤ 10μM |
FLT3-1-E | Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.39 | Binding ≤ 10μM |
KS6A1-1-E | Ribosomal Protein S6 Kinase Alpha 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 560 | 0.27 | Binding ≤ 10μM |
LCK-3-E | Tyrosine-protein Kinase LCK (cluster #3 Of 4), Eukaryotic | Eukaryotes | 20 | 0.34 | Binding ≤ 10μM |
MKNK1-1-E | MAP Kinase-interacting Serine/threonine-protein Kinase MNK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 950 | 0.26 | Binding ≤ 10μM |
SRC-1-E | Tyrosine-protein Kinase SRC (cluster #1 Of 3), Eukaryotic | Eukaryotes | 96 | 0.31 | Binding ≤ 10μM |
VGFR1-1-E | Vascular Endothelial Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2 | 0.38 | Binding ≤ 10μM |
VGFR2-1-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1 | 0.39 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
EPHA2_HUMAN | P29317 | Ephrin Type-A Receptor 2, Human | 740 | 0.27 | Binding ≤ 1μM |
MKNK1_HUMAN | Q9BUB5 | MAP Kinase-interacting Serine/threonine-protein Kinase MNK1, Human | 950 | 0.26 | Binding ≤ 1μM |
KS6A1_HUMAN | Q15418 | Ribosomal Protein S6 Kinase Alpha 1, Human | 560 | 0.27 | Binding ≤ 1μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 20 | 0.34 | Binding ≤ 1μM |
FLT3_HUMAN | P36888 | Tyrosine-protein Kinase Receptor FLT3, Human | 1 | 0.39 | Binding ≤ 1μM |
SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 96 | 0.31 | Binding ≤ 1μM |
VGFR1_HUMAN | P17948 | Vascular Endothelial Growth Factor Receptor 1, Human | 2 | 0.38 | Binding ≤ 1μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 1 | 0.39 | Binding ≤ 1μM |
AAPK2_HUMAN | P54646 | AMP-activated Protein Kinase, Alpha-2 Subunit, Human | 1100 | 0.26 | Binding ≤ 10μM |
AAKB1_HUMAN | Q9Y478 | AMP-activated Protein Kinase, Beta-1 Subunit, Human | 1100 | 0.26 | Binding ≤ 10μM |
AAKG1_HUMAN | P54619 | AMP-activated Protein Kinase, Gamma-1 Subunit, Human | 1100 | 0.26 | Binding ≤ 10μM |
EPHA2_HUMAN | P29317 | Ephrin Type-A Receptor 2, Human | 740 | 0.27 | Binding ≤ 10μM |
MKNK1_HUMAN | Q9BUB5 | MAP Kinase-interacting Serine/threonine-protein Kinase MNK1, Human | 950 | 0.26 | Binding ≤ 10μM |
KS6A1_HUMAN | Q15418 | Ribosomal Protein S6 Kinase Alpha 1, Human | 560 | 0.27 | Binding ≤ 10μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 20 | 0.34 | Binding ≤ 10μM |
FLT3_HUMAN | P36888 | Tyrosine-protein Kinase Receptor FLT3, Human | 1 | 0.39 | Binding ≤ 10μM |
SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 96 | 0.31 | Binding ≤ 10μM |
VGFR1_HUMAN | P17948 | Vascular Endothelial Growth Factor Receptor 1, Human | 2 | 0.38 | Binding ≤ 10μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 1 | 0.39 | Binding ≤ 10μM |
Description | Species |
---|---|
Activation of PPARGC1A (PGC-1alpha) by phosphorylation | |
AMPK inhibits chREBP transcriptional activation activity | |
CD28 co-stimulation | |
CD28 dependent PI3K/Akt signaling | |
CD28 dependent Vav1 pathway | |
Constitutive PI3K/AKT Signaling in Cancer | |
CREB phosphorylation | |
CREB phosphorylation through the activation of Ras | |
CTLA4 inhibitory signaling | |
DAP12 signaling | |
Downstream TCR signaling | |
EPH-ephrin mediated repulsion of cells | |
EPH-Ephrin signaling | |
EPHA-mediated growth cone collapse | |
ERK/MAPK targets | |
Gastrin-CREB signalling pathway via PKC and MAPK | |
Generation of second messenger molecules | |
GPVI-mediated activation cascade | |
Import of palmitoyl-CoA into the mitochondrial matrix | |
Integrin cell surface interactions | |
Interleukin-2 signaling | |
Nef and signal transduction | |
Nef Mediated CD4 Down-regulation | |
Neurophilin interactions with VEGF and VEGFR | |
PD-1 signaling | |
PECAM1 interactions | |
Phosphorylation of CD3 and TCR zeta chains | |
PIP3 activates AKT signaling | |
Recycling pathway of L1 | |
Regulation of AMPK activity via LKB1 | |
Regulation of KIT signaling | |
Regulation of Rheb GTPase activity by AMPK | |
RSK activation | |
Senescence-Associated Secretory Phenotype (SASP) | |
Signaling by ERBB2 | |
Signaling by SCF-KIT | |
Spry regulation of FGF signaling | |
Translocation of GLUT4 to the plasma membrane | |
Translocation of ZAP-70 to Immunological synapse | |
VEGF binds to VEGFR leading to receptor dimerization | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated cell proliferation |
No pre-computed analogs available. Try a structural similarity search.